We are live on ! Find out more
MDRX

Veradigm Inc. Common Stock

Delisted

MDRX was delisted on the 28th of February, 2024.

229 hedge funds and large institutions have $1.39B invested in Veradigm Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 86 increasing their positions, 82 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

93% more call options, than puts

Call options by funds: $2.56M | Put options by funds: $1.33M

5% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 82

4% less capital invested

Capital invested by funds: $1.44B → $1.39B (-$53.4M)

5% less funds holding

Funds holding: 242229 (-13)

34% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 38

Holders
229
Holders Change
-13
Holders Change %
-5.37%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
25
Increased
86
Reduced
82
Closed
38
Calls
$2.56M
Puts
$1.33M
Net Calls
+$1.24M
Net Calls Change
+$2.44M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
151
Bank of Montreal
Ontario, Canada
$208K +$21.5K +1,768 +12%
Creative Planning
152
Creative Planning
Kansas
$203K +$68.3K +5,622 +54%
MHP
153
Manatuck Hill Partners
Connecticut
$198K
CAPTRUST Financial Advisors
154
CAPTRUST Financial Advisors
North Carolina
$192K -$20.3K -1,675 -10%
HSBC Holdings
155
HSBC Holdings
United Kingdom
$184K +$15.4K +1,267 +10%
PAMS
156
Pictet Asset Management (Switzerland)
Switzerland
$183K
PFO
157
Pathstone Family Office
New Jersey
$180K -$2.14K -176 -1%
GT
158
Greenleaf Trust
Michigan
$174K +$5.96K +491 +4%
Amundi
159
Amundi
France
$173K -$23.8K -1,958 -13%
Allspring Global Investments
160
Allspring Global Investments
North Carolina
$168K -$1.38M -113,694 -89%
HF
161
HRT Financial
New York
$142K +$137K +11,286 New
MAM
162
Martingale Asset Management
Massachusetts
$140K -$501K -41,234 -79%
CGH
163
Crossmark Global Holdings
Texas
$137K -$7.99K -658 -6%
AIM
164
Aigen Investment Management
New York
$130K -$99.3K -8,178 -44%
C
165
Covestor
United Kingdom
$118K +$33.5K +2,757 +42%
KBC Group
166
KBC Group
Belgium
$113K
PI
167
PEAK6 Investments
Illinois
$108K -$180K -14,789 -63%
AIP
168
Ameritas Investment Partners
Nebraska
$108K
Osaic Holdings
169
Osaic Holdings
Arizona
$86.1K +$34.8K +2,866 +72%
Fidelity Investments
170
Fidelity Investments
Massachusetts
$84.1K +$4.07K +335 +5%
ACM
171
Aquatic Capital Management
Illinois
$81K -$93.5K -7,700 -55%
KI
172
Kapitalo Investimentos
Brazil
$78.9K +$76.1K +6,264 New
MLICM
173
Metropolitan Life Insurance Company (MetLife)
New York
$75.4K
TRCT
174
Tower Research Capital (TRC)
New York
$66.9K +$31.4K +2,587 +95%
Nisa Investment Advisors
175
Nisa Investment Advisors
Missouri
$61.7K -$4.82K -397 -7%

MDRX Hedge Fund Activity: Q2 2023 in Review

229 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Veradigm Inc. Common Stock (MDRX) for Q2 2023, worth a combined $1.39B — down 3.7% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of MDRX and 25 opened new positions — a net loss of 13 holders — while 82 trimmed existing stakes and 86 added.

The largest buyer was Point72 Asset Management, adding an estimated $23.6M. The largest seller was Bank of America, cutting an estimated $18.2M.

  • 229 institutional investors held Veradigm Inc. Common Stock (MDRX) as of Q2 2023, down from 242 in Q1 2023.
  • Funds reported $1.39B of Veradigm Inc. Common Stock stock for Q2 2023, down 3.7% quarter-over-quarter.
  • 25 funds opened new Veradigm Inc. Common Stock positions in Q2 2023 and 38 closed out, a net change of -13 holders.
  • The largest Veradigm Inc. Common Stock buyer in Q2 2023 was Point72 Asset Management, an estimated $23.6M added.
  • The largest Veradigm Inc. Common Stock seller in Q2 2023 was Bank of America, an estimated $18.2M sold.

Based on aggregated 13F filings for Q2 2023.